ORACLE INVESTMENT MANAGEMENT INC
CIK 1012622 · Holdings on Dec 31, 2024 · First reported Feb 14, 2025
Top ten holdings
Q4 2024- WGS52.82%
- BHVN21.36%
- ARDX7.11%
- SWTX6.18%
- QDEL3.54%
- BCRX2.70%
- 34630N1061.89%
- PLTR1.45%
- CAVA1.41%
- PHAT0.79%
Share classes counted separately99.25%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- WGSWeight increased · +17.35 pp35.47% → 52.82%Shares -22.30K (-2.13%)
- PHATWeight decreased · -10.04 pp10.83% → 0.79%Shares -604.42K (-80.64%)
- BHVNWeight decreased · -6.81 pp28.17% → 21.36%Shares +146.52K (+20.78%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 13
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | WGSGENEDX HOLDINGS CORPCOM CL A View history and evidence | $78.66M | 52.82% | 1.02M shares | 35.47% → 52.82%+17.35 pp -22.30K (-2.13%) | Reduced | ↗▾ |
| 02 | BHVNBIOHAVEN LTD View history and evidence | $31.81M | 21.36% | 851.77K shares | 28.17% → 21.36%-6.81 pp +146.52K (+20.78%) | Added | ↗▾ |
| 03 | ARDXARDELYX INC View history and evidence | $10.59M | 7.11% | 2.09M shares | 7.54% → 7.11%-0.43 pp +720.23K (+52.60%) | Added | ↗▾ |
| 04 | SWTXSPRINGWORKS THERAPEUTICS INC View history and evidence | $9.20M | 6.18% | 254.77K shares | 0.88% → 6.18%+5.30 pp +220.57K (+644.95%) | Added | ↗▾ |
| 05 | QDELQUIDELORTHO CORP View history and evidence | $5.27M | 3.54% | 118.29K shares | 4.31% → 3.54%-0.77 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | BCRXBIOCRYST PHARMACEUTICALS INC View history and evidence | $4.03M | 2.70% | 535.56K shares | 3.25% → 2.70%-0.55 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | 34630N106FORIAN INC View history and evidence | $2.81M | 1.89% | 1.37M shares | 2.34% → 1.89%-0.45 pp +10.00K (+0.74%) | Added | ↗▾ |
| 08 | PLTRPALANTIR TECHNOLOGIES INC-ACL A View history and evidence | $2.16M | 1.45% | 28.50K shares | 0.82% → 1.45%+0.63 pp +1.00K (+3.64%) | Added | ↗▾ |
| 09 | CAVACAVA GROUP INC View history and evidence | $2.10M | 1.41% | 18.60K shares | 1.84% → 1.41%-0.43 pp 0 (0.00%) | Unchanged | ↗▾ |
| 10 | PHATPHATHOM PHARMACEUTICALS INC View history and evidence | $1.18M | 0.79% | 145.06K shares | 10.83% → 0.79%-10.04 pp -604.42K (-80.64%) | Reduced | ↗▾ |
Options overlay 6
$34.72M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
XLVSS HEALTH CARE SELECT SECTORPUT View history and evidence | Put | 115.00K | $15.82M | +115.00K | ▾ |
BHVNBIOHAVEN LTDCALL View history and evidence | Call | 200.00K | $7.47M | -102.70K (-33.93%) | ▾ |
NVAXNOVAVAX INCCALL View history and evidence | Call | 466.00K | $3.75M | -68.60K (-12.83%) | ▾ |
3 / 6 options · preview only
Exited positions 6
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| XBI SS SPDR S&P BIOTECH ETF | Call | -100,000 | -$9.88M | SEC filing ↗ | SEC filing ↗ |
| MYGN MYRIAD GENETICS INC | Non-derivative | -134,500 | -$3.68M | SEC filing ↗ | SEC filing ↗ |
| PHAT PHATHOM PHARMACEUTICALS INC | Call | -192,700 | -$3.48M | SEC filing ↗ | SEC filing ↗ |
3 / 6 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1012622 · Period 2024-12-31
Data loaded 2026-09-23 · First reported 2025-02-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 183665090
}Take these holdings further.
This page includes 19 of 19 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 19 of 19 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1012622","quarter":"2024Q4","page_size":100}
get_institutional_manager_history
{"cik":"1012622","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.